China-US biotech startup raises money for flu drug
Lilly Asia Ventures, Oceanpine Capital, Matrix Partners China are betting on Ansun BioPharma to kill the virus on your respiratory tract.
October 14, 2019
- News
-
Investment Lifecycle
Deals & Trends
Rainmakers
Regions
- Research
-
- Awards
-
- Events
- Photo Gallery
